Stockscreener 앱 받기
0.7922
3.40%
-0.0279
시간 외 거래:
.79
-0.0022
-0.28%
전일 마감가:
$0.8201
열려 있는:
$0.844
하루 거래량:
1.09M
Relative Volume:
1.44
시가총액:
$231.83M
수익:
$6.23M
순이익/손실:
$-95.90M
주가수익비율:
5.2813
EPS:
0.15
순현금흐름:
$-68.47M
1주 성능:
-20.78%
1개월 성능:
-16.88%
6개월 성능:
-42.59%
1년 성능:
-32.86%
1일 변동 폭
$0.79
$0.8499
1주일 범위
$0.7811
$1.00
52주 변동 폭
$0.7811
$1.93
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
PGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| PGEN | 0.7922 | 231.83M | 6.23M | -95.90M | -68.47M | 0.15 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
HC Wainwright Reduces Earnings Estimates for Precigen - MarketBeat
PGEN stock touches 52-week low at $0.78 amid market challenges - Investing.com Canada
HC Wainwright Reiterates Buy Rating for Precigen (NASDAQ:PGEN) - MarketBeat
Precigen Inc. (PGEN) Quarterly 10-Q Report - Quartzy
Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Precigen Inc (PGEN) Q3 2024 Earnings: EPS Misses at $(0.09), Rev - GuruFocus.com
Precigen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Precigen Reports Third Quarter 2024 Financial Results and Business Updates - Quantisnow
Precigen (NASDAQ:PGEN) Shares Cross Below 200 Day Moving AverageHere's Why - MarketBeat
Precigen CEO to Present at Stifel 2024 Healthcare Conference: Gene Therapy Innovation Spotlight | PGEN Stock News - StockTitan
Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Price Target from Brokerages - Defense World
Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Target Price from Analysts - MarketBeat
PGEN (Precigen) EBITDA per Share : $-0.52 (TTM As of Jun. 2024) - GuruFocus.com
Precigen Announces Pricing of $30.0 Million Public Offering of C - GuruFocus.com
Iridian Asset Management LLC CT Grows Stock Position in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat
PGEN stock touches 52-week low at $0.82 amid market challenges - Investing.com Australia
Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th - GuruFocus.com
High Growth Tech Stocks To Watch In October 2024 - Simply Wall St
Should you Hold Precigen (PGEN)? - Insider Monkey
Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
A company insider recently bought 58,823 shares of Precigen Inc [PGEN]. Should You Buy? - Knox Daily
Precigen reclaims rights after terminating license agreement By Investing.com - Investing.com Australia
Precigen Inc (PGEN) stock analysis: A simple moving average approach - US Post News
Precigen reclaims rights after terminating license agreement - Investing.com India
Precigen Terminates License Agreement With Alaunos Therapeutics - MarketWatch
Precigen Regains Full Control of Technology Post Agreement Termination - TipRanks
Precigen : Termination of Material Agreement Form 8 K - Marketscreener.com
Upward Trajectory: Precigen Inc (PGEN) Posts a Slidee, Closing at 0.85 - The Dwinnex
When Will Precigen, Inc. (NASDAQ:PGEN) Turn A Profit? - Simply Wall St
PGEN’s latest rating updates from top analysts. - Knox Daily
Is Precigen Inc (PGEN) positioned for future growth? - SETE News
SVP, IP Affairs Perez Jeffrey Thomas acquire 58,823 shares of Precigen Inc [PGEN] - Knox Daily
Precigen (NASDAQ:PGEN) Shares Cross Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
How to interpret Precigen Inc (PGEN)’s stock chart patterns - US Post News
5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io
Financial Analysis: Precigen Inc (PGEN)’s Ratios Unveil Key Insights - The Dwinnex
Precigen Inc (PGEN) receives an Underweight rating from JP Morgan - Knox Daily
Precigen's SWOT analysis: biotech firm's stock rides on PRGN-2012 success - Investing.com
Precigen Inc (PGEN)’s stock performance: a year in review - US Post News
Biotech Co. Precigen Announces IP Exec's Departure - Law360
Precigen Inc (PGEN) may enjoy gains as insiders got busy in the recent days - Knox Daily
Precigen senior VP Jeffrey Perez quits - Investing.com
J.P. Morgan cuts Precigen to underweight, cites burn rate - MSN
Precigen Inc Inc. (PGEN) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Precigen Inc [NASDAQ: PGEN] Sees Increase in Stock Value - Knox Daily
What is Precigen Inc (PGEN) Stock Return on Shareholders’ Capital? - SETE News
Investing in Precigen Inc (PGEN): What You Must Know - Knox Daily
The Precigen Inc (PGEN) had a good session last reading, didn’t it? - US Post News
Precigen Inc’s Market Journey: Closing Weak at 1.00, Down -4.78 - The Dwinnex
Analysts Set Precigen, Inc. (NASDAQ:PGEN) Target Price at $7.00 - MarketBeat
Principal Financial Group Inc. Sells 37,802 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):